Page last updated: 2024-11-11

isomangiferin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isomangiferin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

isomangiferin : A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, 6 and 7 and a 1,5-anhydro-D-glucitol moiety at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5318597
CHEBI ID80840
SCHEMBL ID20597612
MeSH IDM0170513

Synonyms (22)

Synonym
isomangiferin
24699-16-9
C16979
9h-xanthen-9-one, 4-beta-d-glucopyranosyl-1,3,6,7-tetrahydroxy-
CHEBI:80840
(1s)-1,5-anhydro-1-(1,3,6,7-tetrahydroxy-9-oxo-9h-xanthen-4-yl)-d-glucitol
CS-4662
AC-35047
Q-100321
HY-N0772
AKOS024465129
DTXSID30179435
4-beta-d-glucopyranosyl-1,3,6,7-tetrahydroxy-9h-xanthen-9-one
4-glucosyl-1,3,6,7-tetrahydroxyxanthone
SCHEMBL20597612
Q27151338
4-c-glucosyl-1,3,6,7-tetrahydroxyxanthone
JJ747C4BW7
1,3,6,7-tetrahydroxy-4-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-9h-xanthen-9-one
mfcd00238624
9h-xanthen-9-one, 4-ss-d-glucopyranosyl-1,3,6,7-tetrahydroxy-
AS-77281

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The validated method has been successfully applied to a preclinical pharmacokinetic study of isomangiferin in rats for the first time."( Development and validation of a liquid chromatography with tandem mass spectrometry method for the determination of isomangiferin in rat plasma with application to a preclinical pharmacokinetic study.
Liu, Z; Sun, F; Xia, P; Yang, B, 2016
)
0.86
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
anti-HSV-1 agentAn anti-HSV agent agent that destroys or inhibits the replication of herpes simplex virus-1.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
xanthonesAny member of the class of xanthenes based on a xanthone skeleton.
C-glycosyl compoundA glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a carbon atom, thus creating a C-C bond.
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's2 (14.29)18.2507
2000's4 (28.57)29.6817
2010's6 (42.86)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.36 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]